Diacar drug effect on blood sugar

Evaluation of Diacare (Herbal Anti diabetic drug) on hyperglycemia in diabetic patient type2: clinical trial double blind

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015110824940N1

Enrollment

Registered

2016-01-04

Start date

2015-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabet. Diabetes mellitus

Interventions

Intervention 1: Diacar capsule 500 mg, 4 times a day for 4 months. Intervention 2: Oral placebo capsules similar to the main drug used 4 times a day for 4 months.

Treatment - Drugs

Placebo

Diacar capsule 500 mg, 4 times a day for 4 months

Oral placebo capsules similar to the main drug used 4 times a day for 4 months

Eligibility

Sex/Gender

All

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: In this study diabetic patients type II on the basis of ADA criteria, aged 60-40 year with at least 2 years history of diabetes to be diabetic patients was selected. The exclusion criteria are: secondary infection, cardiovascular disease, pregnancy and lactation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1C. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Spectrometer according percent.;FBS. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer (mg/dl).;Metformin. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: The number of daily consumption.	—

Measure

Time frame

HbA1C. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Spectrometer according percent.;FBS. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer (mg/dl).;Metformin. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: The number of daily consumption.

—

Secondary

Measure	Time frame
SGPT. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;ALK. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;BUN. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;Creatinine. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;TC. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;TG. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(U/Ll).;HDL. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(U/Ll).;LDL. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(U/Ll).;SGOT. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).	—

Measure

Time frame

SGPT. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;ALK. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;BUN. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;Creatinine. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;TC. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).;TG. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(U/Ll).;HDL. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(U/Ll).;LDL. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(U/Ll).;SGOT. Timepoint: Before the start of the study- After two months, After 4 months. Method of measurement: Autoanalyzer(mg/dl).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Amin Kouhpayeh

Fasa Univrrsity of Medical Sciences

kouhpayeha@fumus.ac.ir; kouhpayeha@gmail.com+98 71 5335 7091

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026